N. Arnaud, S. Dabo, P. Maillard, A. Budkowska, K. I. Kalliampakou et al., Hepatitis C Virus Controls Interferon Production through PKR Activation, PLoS ONE, vol.5, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-00488757

A. Athanasiadis, D. Placido, S. Maas, B. A. Brown, K. Lowenhaupt et al., The Crystal Structure of the Z? Domain of the RNA-editing Enzyme ADAR1 Reveals Distinct Conserved Surfaces Among Z-domains, J. Mol. Biol, vol.351, pp.496-507, 2005.


M. L. Baker, T. Schountz, and L. Wang, Antiviral immune responses of bats: a review, Zoonoses Public Health, vol.60, pp.104-116, 2013.

L. Bazak, A. Haviv, M. Barak, J. Jacob-hirsch, P. Deng et al., A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes, Genome Res, vol.24, pp.365-376, 2014.

M. C. Bonnet, C. Daurat, C. Ottone, and E. F. Meurs, The N-terminus of PKR is responsible for the activation of the NF-?B signaling pathway by interacting with the IKK complex, Cell. Signal, vol.18, pp.1865-1875, 2006.

E. C. Borden, G. C. Sen, G. Uze, R. H. Silverman, R. M. Ransohoff et al., Interferons at age 50: past, current and future impact on biomedicine, Nat. Rev. Drug Discov, vol.6, pp.975-990, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00203077

G. Clerzius, J. Gélinas, A. Daher, M. Bonnet, E. F. Meurs et al., ADAR1 Interacts with PKR during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral Replication, J. Virol, vol.83, pp.10119-10128, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-00460530


P. C. Cruz-rivera, M. Kanchwala, H. Liang, A. Kumar, L. Wang et al., The IFN Response in Bats Displays Distinctive IFN-Stimulated Gene Expression Kinetics with Atypical RNASEL Induction, J. Immunol, vol.200, pp.209-217, 2018.

S. Dabo and E. F. Meurs, dsRNA-Dependent Protein Kinase PKR and its Role in Stress, Signaling and HCV Infection, Viruses, vol.4, pp.2598-2635, 2012.

S. D. Der, A. Zhou, B. R. Williams, and R. H. Silverman, Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays, Proc. Natl. Acad. Sci. U. S. A, vol.95, pp.15623-15628, 1998.

M. Dey, C. Cao, F. Sicheri, and T. E. Dever, Conserved Intermolecular Salt Bridge Required for Activation of Protein Kinases PKR, GCN2, and PERK, J. Biol. Chem, vol.282, pp.6653-6660, 2007.

M. Doria, F. Neri, A. Gallo, M. G. Farace, and A. Michienzi, Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection, Nucleic Acids Res, vol.37, pp.5848-5858, 2009.

E. Elkhateeb, H. T. Tag-el-din-hassan, N. Sasaki, D. Torigoe, M. Morimatsu et al., The role of mouse 2?,5?-oligoadenylate synthetase 1 paralogs, Infect. Genet. Evol, vol.45, pp.393-401, 2016.

I. Fierro-monti and M. B. Mathews, Proteins binding to duplexed RNA: one motif, multiple functions, Trends Biochem. Sci, vol.25, issue.00, pp.1580-1582, 2000.

U. Garaigorta and F. V. Chisari, Hepatitis C Virus Blocks Interferon Effector Function by Inducing PKR Phosphorylation, Cell Host Microbe, vol.6, pp.513-522, 2009.


M. A. García, E. F. Meurs, and M. Esteban, The dsRNA protein kinase PKR: Virus and cell control, Biochimie, vol.89, pp.799-811, 2007.

J. L. Guénet, F. Benavides, J. Panthier, and X. Montagutelli, Genetics of the Mouse, 2015.

. Springer-berlin-heidelberg and . Chapters, , vol.408

C. X. George and C. E. Samuel, Characterization of the 5'-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter, Gene, vol.229, pp.203-213, 1999.

A. Ghosh, S. N. Sarkar, W. Guo, S. Bandyopadhyay, and G. C. Sen, Enzymatic activity of 2'-5'-oligoadenylate synthetase is impaired by specific mutations that affect oligomerization of the protein, J. Biol. Chem, vol.272, pp.33220-33226, 1997.

R. A. Goodman, M. R. Macbeth, and P. A. Beal, ADAR proteins: structure and catalytic mechanism, Curr. Top. Microbiol. Immunol, vol.353, pp.1-33, 2012.

X. He, T. Korytá?, Y. Zhu, J. Pikula, H. Bandouchova et al., Establishment of Myotis myotis cell lines--model for investigation of host-pathogen interaction in a natural host for emerging viruses, PloS One, vol.9, 2014.

A. Herbert, J. Alfken, Y. Kim, I. S. Mian, K. Nishikura et al., A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase, Proc. Natl. Acad. Sci. U. S. A, vol.94, pp.8421-8426, 1997.

J. Justesen, R. Hartmann, and N. O. Kjeldgaard, Gene structure and function of the 2'-5'-oligoadenylate synthetase family, Cell. Mol. Life Sci. CMLS, vol.57, pp.1593-1612, 2000.

Y. Kim, K. Lowenhaupt, T. Schwartz, and A. Rich, The Interaction between Z-DNA and the Zab Domain of Double-stranded RNA Adenosine Deaminase Characterized Using Fusion Nucleases, J. Biol. Chem, vol.274, pp.19081-19086, 1999.


H. Kristiansen, H. H. Gad, S. Eskildsen-larsen, P. Despres, and R. Hartmann, The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities, 2011.

, J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res, vol.31, pp.41-47

F. Lai, R. Drakas, and K. Nishikura, Mutagenic Analysis of Double-stranded RNA Adenosine Deaminase, a Candidate Enzyme for RNA Editing of Glutamate-gated Ion Channel Transcripts, J. Biol. Chem, vol.270, pp.17098-17105, 1995.


I. Letunic, T. Doerks, and P. Bork, SMART: recent updates, new developments and status in 2015, Nucleic Acids Res, vol.43, pp.257-260, 2015.

D. E. Levy, I. Marié, E. Smith, and A. Prakash, Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback, J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res, vol.22, pp.87-93, 2002.

Y. Liu and C. E. Samuel, Mechanism of interferon action: functionally distinct RNAbinding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase, J. Virol, vol.70, pp.1961-1968, 1996.

K. Malathi, B. Dong, M. Gale, and R. H. Silverman, Small self-RNA generated by RNase L amplifies antiviral innate immunity, Nature, vol.448, pp.816-819, 2007.


K. Malathi, J. M. Paranjape, E. Bulanova, M. Shim, J. M. Guenther-johnson et al., A transcriptional signaling pathway in the IFN system mediated by 2?-5?-oligoadenylate activation of RNase L, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.14533-14538, 2005.

N. Mannion, F. Arieti, A. Gallo, L. P. Keegan, and M. A. O'connell, New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins, Biomolecules, vol.5, pp.2338-2362, 2015.

I. Marié, J. Blanco, D. Rebouillat, and A. G. Hovanessian, 69-kDa and 100-kDa isoforms of interferon-induced (2'-5')oligoadenylate synthetase exhibit differential catalytic parameters, Eur. J. Biochem, vol.248, pp.558-566, 1997.

S. J. Mccormack, L. G. Ortega, J. P. Doohan, and C. E. Samuel, Mechanism of Interferon Action Motif I of the Interferon-Induced, RNA-Dependent Protein Kinase (PKR) Is Sufficient to Mediate RNA-Binding Activity, Virology, vol.198, pp.92-99, 1994.


E. Meurs, K. Chong, J. Galabru, N. S. Thomas, I. M. Kerr et al., Molecular cloning and characterization of the human doublestranded RNA-activated protein kinase induced by interferon, Cell, vol.62, pp.379-390, 1990.

E. F. Meurs, Y. Watanabe, S. Kadereit, G. N. Barber, M. G. Katze et al., Constitutive expression of human double-stranded RNAactivated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth, J. Virol, vol.66, pp.5805-5814, 1992.

R. Moratelli and C. H. Calisher, Bats and zoonotic viruses: can we confidently link bats with emerging deadly viruses?, Mem. Inst. Oswaldo Cruz, vol.110, pp.1-22, 2015.

J. A. Pulit-penaloza, S. V. Scherbik, and M. A. Brinton, Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation, Virology, vol.425, pp.71-81, 2012.

M. Saraste, P. R. Sibbald, and A. Wittinghofer, The P-loop--a common motif in ATP-and GTP-binding proteins, Trends Biochem. Sci, vol.15, pp.430-434, 1990.

S. N. Sarkar, M. Miyagi, J. W. Crabb, and G. C. Sen, Identification of the substrate-binding sites of 2'-5'-oligoadenylate synthetase, J. Biol. Chem, vol.277, pp.24321-24330, 2002.

S. Sarkis, M. Lise, E. Darcissac, S. Dabo, M. Falk et al., Development of molecular and cellular tools to decipher the type I IFN pathway of the common vampire bat, Dev. Comp. Immunol, vol.81, pp.1-7, 2018.
URL : https://hal.archives-ouvertes.fr/pasteur-01633796

G. C. Sen, Viruses and Interferons, Annu. Rev. Microbiol, vol.55, pp.255-281, 2001.

A. E. Shaw, J. Hughes, Q. Gu, A. Behdenna, J. B. Singer et al., Fundamental properties of the mammalian innate immune system revealed by multispecies comparison of type I interferon responses, PLOS Biol, vol.15, 2017.

R. H. Silverman, Implications for RNase L in Prostate Cancer Biology, Biochemistry (Mosc.), vol.42, pp.1805-1812, 2003.

H. T. Tag-el-din-hassan, N. Sasaki, K. Moritoh, D. Torigoe, A. Maeda et al., The chicken 2'-5' oligoadenylate synthetase A inhibits the replication of West Nile virus, Jpn. J. Vet. Res, vol.60, pp.95-103, 2012.

K. Tamura, G. Stecher, D. Peterson, A. Filipski, and S. Kumar, MEGA6: Molecular Evolutionary Genetics Analysis version 6.0, Mol. Biol. Evol, vol.30, pp.2725-2729, 2013.

B. R. Williams, Signal Integration via PKR, Sci STKE, pp.2-2, 2001.

Y. Xiang, Z. Wang, J. Murakami, S. Plummer, E. A. Klein et al., Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates, Cancer Res, vol.63, pp.6795-6801, 2003.

Y. Yamamoto, D. Sono, and Y. Sokawa, Effects of specific mutations in active site motifs of 2',5'-oligoadenylate synthetase on enzymatic activity, J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res, vol.20, pp.337-344, 2000.

P. Zhou, C. Cowled, L. Wang, and M. L. Baker, Bat Mx1 and Oas1, but not Pkr are highly induced by bat interferon and viral infection, Dev. Comp. Immunol, vol.40, pp.240-247, 2013.

P. Zhou, M. Tachedjian, J. W. Wynne, V. Boyd, J. Cui et al., Contraction of the type I IFN locus and unusual constitutive expression of IFN-? in bats, 2016.

, Proc. Natl. Acad. Sci. U. S. A, vol.113, pp.2696-2701

, ADAR1/PKR (XM_015598363/NM_0012910168), HsADAR1/PKR: Homo sapiens ADAR1/PKR 622 (NM_001111/XM_011532987), MmADAR1/PKR: Mus musculus ADAR1/PKR